Literature DB >> 15053

Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats.

A Nagy.   

Abstract

Imipramine and clomipramine were administered to rats by the oral and intramuscular routes as single and multiple doses. The concentrations of both drugs and their active demethylated metabolites desipramine and desmethylclomipramine were measured in blood plasma, blood cells and brain. The concentrations of the metabolites were higher and the concentrations of the parent substances lower after oral than after parenteral administration, both in blood and in brain. In brain imipramine, despiramine and clomipramine during continuous treatment exceeded their plasma concentrations by six to ten times. The corresponding figure for desmethylclomipramine was 1-7. The extent of accumulation of the investigated substances in the brain was independent of the route of administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15053     DOI: 10.1111/j.2042-7158.1977.tb11255.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  23 in total

1.  Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

2.  A study of the sensitivity of rat brain alpha 2-adrenoceptors during chronic antidepressant treatments.

Authors:  M F Sugrue
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

3.  Tricyclic antidepressant drugs and individual differences in the exploratory activity of rats: contrasting effects of tertiary and secondary amine compounds.

Authors:  P E Harrison-Read; H Steinberg
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.

Authors:  J B Lassen; J Lund; I Søndergaard
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 5.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.

Authors:  C L DeVane; J W Simpkins; S A Stout
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Influence of naloxone on antidepressant drug effects in the forced swimming test in mice.

Authors:  J L Devoize; F Rigal; A Eschalier; J F Trolese; M Renoux
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Separation and quantitative determination of imipramine and desipramine from rat biological samples by high pressure liquid chromatography.

Authors:  A Bonora; P A Borea
Journal:  Experientia       Date:  1978-11-15

9.  Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.

Authors:  S O Ogren; K Fuxe; L F Agnati; J A Gustafsson; G Jonsson; A C Holm
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

10.  Phase I metabolism of imipramine by microsomes of small intestine in comparison with metabolism by liver microsomes.

Authors:  W Christ; W Hecker; H Junge; G Stille
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.